Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic side effects.

R A Gleckman1, J S Czachor

  • 1St. Joseph's Hospital and Medical Center, Paterson, New Jersey 07503, USA.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Knowledge acquisition in a one-month infectious diseases rotation.

Academic medicine : journal of the Association of American Medical Colleges·2000
Same author

Transmission of Strongyloides steracolis person to person.

Journal of travel medicine·2000
Same author

Antibiotic troubleshooting in primary care.

Hospital practice (1995)·1999
Same author

APACHE II and ISS scores as predictors of nosocomial infections in trauma patients.

American journal of infection control·1999
Same author

A review of selective infections in the adult diabetic.

Comprehensive therapy·1999
Same author

The use of fluconazole as a local irrigant for nephrostomy tubes.

Military medicine·1999
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Antibiotics can cause serious toxicity and drug interactions, leading to patient harm and increased costs. Understanding these adverse events is crucial, especially for vulnerable patient groups.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Growing concern over medication-induced toxicity, with media highlighting antibiotic risks.
  • Drug-related toxicity identified as a leading cause of death in hospitalized patients.
  • Antibiotic adverse events contribute to patient injury, diagnostic challenges, and elevated healthcare expenses.

Purpose of the Study:

  • To detail adverse events and drug-drug interactions of commonly prescribed antibiotics for respiratory infections.
  • To emphasize unique patient populations requiring specialized knowledge of antibiotic-induced adverse events.

Main Methods:

  • Review of adverse events and drug-drug interactions associated with common respiratory antibiotics.
  • Focus on specific patient populations including those with renal insufficiency, on immunosuppressants, pregnant, elderly, and HIV-infected individuals.

Related Experiment Videos

Main Results:

  • Antibiotics can lead to significant host injury, diagnostic confusion, and increased medical costs.
  • A critical consequence of antibiotic adverse events is the rise of drug-resistant organisms.
  • Specific patient profiles necessitate careful consideration of antibiotic-induced adverse events.

Conclusions:

  • Knowledge of antibiotic-induced adverse events and drug-drug interactions is vital for safe prescribing.
  • Special attention is required for vulnerable populations to mitigate risks associated with antibiotic therapy.
  • Addressing antibiotic adverse events is essential for patient safety and combating antimicrobial resistance.